The modifying Res by substituting a methyl group on the hydroxy group of ring A and introducing a methoxy group at the para position of ring B to create the compound SM-3 results in a more effective targeted suppression of CSCs through the inhibition of the mTOR protein in lung cancer cells. Here, MTOR is linked to lung carcinoma.